[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1973

Pemphigus Treatment with AzathioprineClinical and Immunologic Correlation

Author Affiliations

Cleveland

From the departments of dermatology (Dr. Roenigk) and immunopathology (Dr. Deodhar), Cleveland Clinic Foundation, Cleveland.

Arch Dermatol. 1973;107(3):353-357. doi:10.1001/archderm.1973.01620180007002
Abstract

A prospective study of ten patients with early pemphigus, who were treated with azathioprine, is described. The dosage of azathioprine was 50 to 250 mg/day. Nine of the ten patients had good to excellent results. Seven of the ten patients were either never given corticosteroids or had the corticosteroids completely withdrawn. There was good clinical and immunologic correlation in eight of the ten patients. There were no significant side-effects and no wound-healing problems. High-dose corticosteroid therapy is still the treatment of choice for severe, generalized, toxic pemphigus, but in early pemphigus azathioprine alone may control the disease.

×